Procurement of CPD Courses

The Irish Institute of Pharmacy (IIOP) will commission a defined set of education and training programmes each year in line with national policy and evolving healthcare needs.

These programmes will be procured in line with the IIOP’s procurement policy and processes.

IIOP’s approach to the procurement process reflects not only good business practice in relation to the making of purchasing decisions  but may also encompass national and EU rules and regulations.

The IIOP strives to ensure that all procurement activity is discharged honestly, fairly, and in a manner that secures best value for money. IIOP must be cost effective and efficient in the use of resources while upholding high standards of probity and integrity.

Training providers who wish to be included on the IIOP’s register of interested parties should contact procurement@iiop.ie

Return to Training Providers .

Procurement Update:  

The IIOP/RCSI awarded the following contracts:

 

Training Programme Training Provider Date of contract

Diagnosis and Treatment of an Acute Asthmatic Attack and the Supply and Administration of Salbutamol

Hibernian Healthcare 23 September 2019
Mentoring skills for Pharmacists  Kingstown College 23 September 2019
Biological Medicines: Supporting your patients  Hibernian Healthcare 6 September 2019
Oral Anti-Cancer Medicines  Hibernian Healthcare 2 September 2019
Anticoagulation Training Programme NI Centre for Pharmacy Learning and Development 1 July 2019
Cardiovascular Risk NI Centre for Pharmacy Learning and Development 1 July 2019
Diabetes Training Programme NI Centre for Pharmacy Learning and Development 1 July 2019
Diagnosis and Treatment of Hypoglycaemia and the Supply and Administration of Glucagon NI Centre for Pharmacy Learning and Development 1 July 2019
Diagnosis and Treatment of a Severe Angina Attack and the Supply and Administration of Glyceryl Trinitrate NI Centre for Pharmacy Learning and Development 1 July 2019
Managing Quality in Pharmacy Practice and Quality Improvement in the Supply of High Risk Medicines Pharmapod 28 June 2019